Diltiazem Hci 51662-1457
Product NDC
51662-1457- Manufacturer
- Hf Acquisition Co Llc, Dba Healthfirst
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- December 15, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA075853
Need to source Diltiazem Hci? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Diltiazem Hydrochloride | 100 mg/1 |
Drug Class
Calcium Channel Antagonists [MoA]Calcium Channel Blocker [EPC]Cytochrome P450 3A4 Inhibitors [MoA]
Packaging Options(2)
1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (51662-1457-1)
10 POUCH in 1 CASE (51662-1457-3) / 1 VIAL, PATENT DELIVERY SYSTEM in 1 POUCH (51662-1457-2) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM